Cargando…
Prevention and treatment of venous thromboembolism during HRT: current perspectives
Many large trials in the past 15 years have proven an increased risk of vascular complications in women using oral, mostly non-bioidentical, hormone therapy. The risk of vascular complications depends on the route of administration (oral versus transdermal), age, duration of administration, and type...
Autor principal: | Rott, Hannelore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155999/ https://www.ncbi.nlm.nih.gov/pubmed/25210472 http://dx.doi.org/10.2147/IJGM.S46310 |
Ejemplares similares
-
HRT Specification
por: Möller, M, et al.
Publicado: (1996) -
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
por: Zalpour, Ali, et al.
Publicado: (2014) -
Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
por: Poenou, Geraldine, et al.
Publicado: (2022) -
HRT Access Grid
por: Department, HR
Publicado: (2014) -
Venous Thromboembolism – Current Diagnostic and Treatment Modalities
por: Bosevski, Marijan, et al.
Publicado: (2016)